NCT02363400 2025-08-19
A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA
National Health Research Institutes, Taiwan
Phase 3 Terminated
National Health Research Institutes, Taiwan
National Institutes of Health Clinical Center (CC)